Results 171 to 180 of about 108,257 (197)

A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis. [PDF]

Ann Hematol
Abu-Zeinah G, Qin A, Gill H, Komatsu N, Mascarenhas J, Shih WJ, Zagrijtschuk O, Sato T, Shimoda K, Silver RT, Mesa R.   +10 more
europepmc   +1 more source

Pathophysiology of and Therapy for Primary Myelofibrosis

Nihon Naika Gakkai Zasshi, 2007
openaire   +3 more sources

Metastatic splenic angiosarcoma presenting with anemia and bone marrow fibrosis mimicking primary myelofibrosis: A case report and literature review. [PDF]

Mol Clin Oncol
Wu M, Li Z, Luo L, Zhao W, Luo J.
europepmc   +1 more source

Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression. [PDF]

Int J Mol Sci
Tripodi J, Hoffman R, Tremblay D, Ahire D, Mascarenhas J, Kremyanskaya M, Najfeld V.   +6 more
europepmc   +1 more source

Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients. [PDF]

Antioxidants (Basel)
Mangione R, Giallongo C, Duminuco A, La Spina E, Longhitano L, Giallongo S, Tibullo D, Lazzarino G, Saab MW, Sbriglione A, Palumbo GA, Graziani A, Alanazi AM, Di Pietro V, Tavazzi B, Amorini AM, Lazzarino G.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prognostication in Primary Myelofibrosis

Current Hematologic Malignancy Reports, 2011
Primary myelofibrosis (PMF) is a Philadelphia chromosome-negative chronic myeloproliferative neoplasm usually affecting elderly people. Median survival currently approaches 6 years, with a few patients surviving more than 20 years but others dying soon after diagnosis. In 10% to 20% of patients, PMF evolves into acute leukemia.
Francisco Cervantes, Arturo Pereira
openaire   +3 more sources